{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:18:29Z","timestamp":1792718309032,"version":"4.5.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085634","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:50:30Z","timestamp":1389304230000},"page":"e85634","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats"],"prefix":"10.1371","volume":"9","author":[{"given":"Hui-Chun","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"BC Bernardo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Stefan N, Fritsche A, Haring HU (2005) Insulin resistance and congestive heart failure. Jama 294: 2578; author reply 2578.","DOI":"10.1001\/jama.294.20.2578-a"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"S Boudina","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbalip.2005.03.005","article-title":"Fatty acid metabolism is enhanced in type 2 diabetic hearts","volume":"1734","author":"AN Carley","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"LJ Rijzewijk","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/edrv-16-3-390","article-title":"Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide","volume":"16","author":"HC Fehmann","year":"1995","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"C Morimoto","year":"1998","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12325-008-0076-1","article-title":"DPP4 inhibitors: a new approach in diabetes treatment","volume":"25","author":"J Doupis","year":"2008","journal-title":"Adv Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00210-008-0280-0","article-title":"Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?","volume":"377","author":"MC Michel","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref10","first-page":"989","article-title":"Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy\u2013focus on alogliptin","volume":"7","author":"A Capuano","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"K Ban","year":"2008","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/en.2003-0007","article-title":"Cardiac function in mice lacking the glucagon-like peptide-1 receptor","volume":"144","author":"R Gros","year":"2003","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"MH Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00210-010-0559-9","article-title":"GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats","volume":"382","author":"HC Ku","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00210-011-0665-3","article-title":"DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia\/reperfusion","volume":"384","author":"HC Ku","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e17178","DOI":"10.1371\/journal.pone.0017178","article-title":"Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy","volume":"6","author":"AK Vyas","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"H295","DOI":"10.1152\/ajpheart.00990.2012","article-title":"Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes","volume":"305","author":"A Monji","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref18","first-page":"630537","article-title":"Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway","volume":"2013","author":"J Liu","year":"2013","journal-title":"J Diabetes Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10557-013-6459-8","article-title":"The emerging role of dipeptidyl peptidase-4 inhibitors in cardiovascular protection: current position and perspectives","volume":"27","author":"XM Wang","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"M Sauve","year":"2010","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e54518","DOI":"10.1371\/journal.pone.0054518","article-title":"DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes","volume":"8","author":"HC Ku","year":"2013","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrcardio.2012.183","article-title":"Cardiovascular effects of gliptins","volume":"10","author":"AJ Scheen","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.12000","article-title":"Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials","volume":"15","author":"M Monami","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, <etal>et al<\/etal>.. (2013) Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. N Engl J Med.","DOI":"10.1056\/NEJMoa1307684"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCHEARTFAILURE.108.839761","article-title":"Small animal models of heart failure: development of novel therapies, past and present","volume":"2","author":"RD Patten","year":"2009","journal-title":"Circ Heart Fail"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e27294","DOI":"10.1371\/journal.pone.0027294","article-title":"beta-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure","volume":"6","author":"L Ni","year":"2011","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00210-010-0562-1","article-title":"Thaliporphine ameliorates cardiac depression in endotoxemic rats through attenuating TLR4 signaling in the downstream of TAK-1 phosphorylation and NF-kappaB signaling","volume":"382","author":"WP Chen","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2008.03839.x","article-title":"CD26\/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently","volume":"155","author":"C Klemann","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"H614","DOI":"10.1152\/ajpheart.01143.2008","article-title":"Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models","volume":"297","author":"PJ Guinto","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0008-6363(97)00277-0","article-title":"Alterations of calcium-regulatory proteins in heart failure","volume":"37","author":"G Hasenfuss","year":"1998","journal-title":"Cardiovasc Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCRESAHA.111.242974","article-title":"Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy","volume":"109","author":"H Ashrafian","year":"2011","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/09687680010009646","article-title":"Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure\/function and biology (review)","volume":"17","author":"JM East","year":"2000","journal-title":"Mol Membr Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/hc0802.105564","article-title":"Targeting phospholamban by gene transfer in human heart failure","volume":"105","author":"F Monte del","year":"2002","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Dos Santos L, Salles TA, Arruda-Junior DF, Campos LC, Pereira AC, <etal>et al<\/etal>.. (2013) Circulating Dipeptidyl Peptidase IV Activity Correlates with Cardiac Dysfunction in Human and Experimental Heart Failure. Circ Heart Fail.","DOI":"10.1161\/CIRCHEARTFAILURE.112.000057"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.00454.2012","article-title":"Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice","volume":"304","author":"A Takahashi","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"S Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvn282","article-title":"Metabolic remodelling of the failing heart: beneficial or detrimental?","volume":"81","author":"M van Bilsen","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/01.CIR.0000034049.61181.F3","article-title":"Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice","volume":"106","author":"R Liao","year":"2002","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"LA Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10741-012-9318-y","article-title":"Incretins as a novel therapeutic strategy in patients with diabetes and heart failure","volume":"18","author":"MA Khan","year":"2013","journal-title":"Heart Fail Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1475-2840-12-90","article-title":"Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection","volume":"12","author":"TC Zhao","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"H2401","DOI":"10.1152\/ajpheart.00347.2005","article-title":"Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy","volume":"289","author":"LA Nikolaidis","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-9-76","article-title":"Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure","volume":"9","author":"Q Liu","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1475-2840-8-38","article-title":"A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease","volume":"8","author":"EZ Fisman","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","article-title":"A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity","volume":"127","author":"MH Noyan-Ashraf","year":"2013","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1210\/jc.2012-4288","article-title":"CD26\/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus","volume":"98","author":"SA Lee","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity","volume":"9","author":"C Kappe","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0008-6363(99)00348-X","article-title":"Apoptotic cell death in heart failure","volume":"45","author":"HN Sabbah","year":"2000","journal-title":"Cardiovasc Res"},{"key":"ref49","first-page":"158","article-title":"Aging and Cardiac Fibrosis","volume":"2","author":"A Biernacka","year":"2011","journal-title":"Aging Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-6363(00)00092-4","article-title":"Renin-angiotensin-aldosterone system and myocardial fibrosis","volume":"47","author":"CG Brilla","year":"2000","journal-title":"Cardiovasc Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0008-6363(01)00448-5","article-title":"Is angiotensin II a proliferative factor of cardiac fibroblasts?","volume":"53","author":"F Bouzegrhane","year":"2002","journal-title":"Cardiovasc Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.1210\/jc.2012-3855","article-title":"Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men","volume":"98","author":"J Skov","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbrc.2009.01.003","article-title":"Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model","volume":"380","author":"K Hirata","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e27861","DOI":"10.1371\/journal.pone.0027861","article-title":"Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy","volume":"6","author":"L Chaykovska","year":"2011","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"MM Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/138955707780059853","article-title":"CD26\/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders","volume":"7","author":"MA Thompson","year":"2007","journal-title":"Mini Rev Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T18:18:35Z","timestamp":1688926715000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085634"}},"subtitle":[],"editor":[{"given":"Konrad","family":"Urbanek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085634","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}